Pharmacogenomics links individual drug response variation to genetic differ
ences, such as single nucleotide polymorphisms (SNPs), In particular, pharm
acogenomics will allow clinicians to use genetic diagnostics to predict the
response of a patient to a drug. We investigated whether SNPs in opioid re
ceptors correlated with the development of morphine tolerance in mouse stra
ins that showed either high or low tolerance to morphine. Sequencing identi
fied five silent SNPs in the delta opioid receptor that varied from the pub
lished sequence in some strains, but which were found in both high and low
tolerance strains, The mu and kappa opioid receptor sequences had no SNPs.
Taken together, these data definitively demonstrate that morphine tolerance
development in mice is independent of opioid receptor sequence. (C) 2001 E
lsevier Science Inc.